AzTrials
AzTrials

Osteo Arthritis KneeNCT03385759

Trial of Unicompartmental Versus Total Knee Arthroplasty

A study testing Unicompartmental knee arthroplasty and Total knee arthroplasty in people with Osteo Arthritis Knee, run by Anderson Orthopaedic Research Institute at 2 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is a prospective, randomized trial to compare patient outcomes of unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA) for the treatment of medial compartment osteoarthritis. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Osteo Arthritis Knee
What is being tested?
Unicompartmental knee arthroplasty and Total knee arthroplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
2 sitesUnited States
Study dates
22 May 2018to Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • medial compartment osteoarthritis of the knee
  • knee flexion greater than greater than 90 degrees
  • flexion contracture of less than 10 degrees
  • varus deformity < 20 degrees
  • grade IV degeneration of the medial compartment

Who cannot join

  • lateral compartment degenerative changes
  • previous lateral meniscectomy
  • anterior cruciate ligament deficiency
  • body mass index > 40
  • inflammatory arthritis
  • history of septic arthritis
Show all 11Show fewer
  • hemoglobin A1c > 8.0
  • chronic liver disease
  • stage 3A or greater chronic renal disease
  • active IV drug abuse
  • patients requiring thromboembolic prophylaxis

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Anderson Orthopaedic Research Institute

    Alexandria, Virginia, 22306

  • Rush University Medical Center

    Chicago, Illinois, 60612

Other trials in United States

About this study

Official title: A Prospective Randomized Trial of Unicompartmental Versus Total Knee Arthroplasty for the Treatment of Medial Compartment Osteoarthritis

This study is a prospective, randomized trial to compare patient outcomes of unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA) for the treatment of medial compartment osteoarthritis.

Being tested
Unicompartmental knee arthroplasty, Total knee arthroplasty
Keywords
unicompartmental knee, total knee arthroplasty, osteoarthritis
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Unicompartmental knee arthroplastyProcedure or surgery

    Implant to replace the medial compartment of a patient with knee osteoarthritis

  • Total knee arthroplastyProcedure or surgery

    Implant to replace the knee joint of a patient with knee osteoarthritis

Study groups in NCT03385759
Study groupRoleWhat they receive
UKAActive comparatorMedial unicompartmental knee arthroplasty
Receives: Procedure: Unicompartmental knee arthroplasty
TKAActive comparatorTotal knee arthroplasty
Receives: Procedure: Total knee arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee Society Score

    Functional outcome questionnaire ranging from 0-100, with 100 being best

    Measured: 1 year

  2. Knee Society Score

    Functional knee outcome questionnaire ranging from 0-100, with 100 being best

    Measured: 2 years

Secondary outcomes (1)
  1. Revision

    complication requiring revision surgery

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2017
  2. Study start22 May 2018
  3. Primary completion1 Apr 2023 (estimated)
  4. Study completionJan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
112 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03385759
Sponsor's protocol ID
17-2931
Status last verified
Nov 2022
First submitted
21 Dec 2017
Last updated
14 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Unicompartmental knee arthroplasty and Total knee arthroplasty in people with Osteo Arthritis Knee, run by Anderson Orthopaedic Research Institute at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee Society Score (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in